Collette Houston

1.2k total citations
12 papers, 358 citations indexed

About

Collette Houston is a scholar working on Pathology and Forensic Medicine, Oncology and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Collette Houston has authored 12 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pathology and Forensic Medicine, 3 papers in Oncology and 2 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Collette Houston's work include Ethics in Clinical Research (2 papers), Effects and risks of endocrine disrupting chemicals (2 papers) and Cancer Treatment and Pharmacology (2 papers). Collette Houston is often cited by papers focused on Ethics in Clinical Research (2 papers), Effects and risks of endocrine disrupting chemicals (2 papers) and Cancer Treatment and Pharmacology (2 papers). Collette Houston collaborates with scholars based in United States, Germany and Canada. Collette Houston's co-authors include David P. Kelsen, Susan Derby, Anas Younes, Nancy E. Kemeny, Lynn Adams, Karen Seiter, Dennis Jenke, Daniel L. Norwood, J. McCarthy Lepore and Lei Ren and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Collette Houston

11 papers receiving 345 citations

Peers

Collette Houston

ONCOL

PRM

SURGE

PFM

EPIDE

Anne‐Valérie Guizard France

Gordon E. Searles Canada

Myung Hee Shin South Korea

A. Capobianco Italy

Andrew S. Weiss United States

Emilia Riggi Italy

Pamela Ng Canada

Keiko Sato Japan

Yuan-Chin Amy Lee United States

Ceri White United Kingdom

Anne‐Valérie Guizard France

Collette Houston

269 ×1.6

ONCOL

160 ×2.4

PRM

74 ×1.4

SURGE

21 ×0.5

PFM

76 ×2.2

EPIDE

Citations per year, relative to Collette Houston Collette Houston (= 1×) peers Anne‐Valérie Guizard

Countries citing papers authored by Collette Houston

Since Specialization

Citations

This map shows the geographic impact of Collette Houston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Collette Houston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Collette Houston more than expected).

Fields of papers citing papers by Collette Houston

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Collette Houston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Collette Houston. The network helps show where Collette Houston may publish in the future.

Co-authorship network of co-authors of Collette Houston

This figure shows the co-authorship network connecting the top 25 collaborators of Collette Houston. A scholar is included among the top collaborators of Collette Houston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Collette Houston. Collette Houston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Migliacci, Jocelyn, et al.. (2022). One committee to review it all: A single, multi-disciplinary COVID-19 research committee. Contemporary Clinical Trials. 117. 106760–106760. 1 indexed citations

Buckley, Michael, Allison Lipitz‐Snyderman, Gilad J. Kuperman, et al.. (2022). Digitalizing the Clinical Research Informed Consent Process: Assessing the Participant Experience in Comparison With Traditional Paper-Based Methods. JCO Oncology Practice. 19(3). e355–e364. 3 indexed citations

Buckley, Michael, Allison Lipitz‐Snyderman, Gilad J. Kuperman, et al.. (2022). Electronic research consents for complex early-phase I-II clinical trials integrated with telemedicine visits compared with in-person encounters.. Journal of Clinical Oncology. 40(16_suppl). 1514–1514. 1 indexed citations

Buckley, Michael, Matthew J. Koch, Mary Lin, et al.. (2020). MSK eConsent: Digitalizing the informed consent process to improve participant engagement and understanding.. Journal of Clinical Oncology. 38(15_suppl). 2066–2066. 1 indexed citations

Jenke, Dennis, et al.. (2013). The Product Quality Research Institute (PQRI) Leachables and Extractables Working Group Initiatives for Parenteral and Ophthalmic Drug Product (PODP). PDA Journal of Pharmaceutical Science and Technology. 67(5). 430–447. 46 indexed citations

Jenke, Dennis, Jessica Castner, Todd E. Feinberg, et al.. (2013). Extractables Characterization for Five Materials of Construction Representative of Packaging Systems Used for Parenteral and Ophthalmic Drug Products. PDA Journal of Pharmaceutical Science and Technology. 67(5). 448–511. 44 indexed citations

Jin, Yan, Thomas J. Marrie, Keumhee C. Carrière, et al.. (2003). Variation in management of community-acquired pneumonia requiring admission to Alberta, Canada hospitals. Epidemiology and Infection. 130(1). 41–51. 31 indexed citations

Seidman, Andrew D., Russell K. Portenoy, T. J. Yao, et al.. (1995). Quality of Life in Phase II Trials: a Study of Methodology and Predictive Value in Patients With Advanced Breast Cancer Treated With Paclitaxel Plus Granulocyte Colony-Stimulating Factor. JNCI Journal of the National Cancer Institute. 87(17). 1316–1322. 85 indexed citations

Wu, Danny, et al.. (1992). Selecting a RDBMS for a multi-disciplinary clinical research database. Controlled Clinical Trials. 13(5). 418–419. 1 indexed citations

10.

Lovett, David, David P. Kelsen, Mario A. Eisenberger, & Collette Houston. (1991). A phase II trial of carboplatin and vinblastine in the treatment of advanced squamous cell carcinoma of the esophagus. Cancer. 67(2). 354–356. 17 indexed citations

11.

Kemeny, Nancy E., Anas Younes, Karen Seiter, et al.. (1990). Interferon alpha-2a and 5-fluorouracil for advanced colorectal carcinoma assessment of activity and toxicity. Cancer. 66(12). 2470–2475. 119 indexed citations

12.

Sternberg, Cora N., Alan Yagoda, Howard I. Scher, et al.. (1989). Phase II trial of trimetrexate in patients with advanced renal cell carcinoma. European Journal of Cancer and Clinical Oncology. 25(4). 753–754. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact